Edgewise Therapeutics, Inc. (EWTX) Income Annual - Discounting Cash Flows
EWTX
Edgewise Therapeutics, Inc.
EWTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Report Filing 2025-11-06 2025-03-03 2024-02-22 2023-02-23 2022-02-24 2020-12-31 2019-12-31
Revenue 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0.185 0.123
Gross Profit 0 0 0 0 0 -0.185 -0.123
Operating Expenses 181 158.8 114.4 71.66 43.22 17.01 9.8
Research & Development 144.2 127 90.91 54.03 32.19 14.8 8.62
Selling, General and Administrative 36.8 31.87 23.45 17.63 11.03 2.21 1.3
Other Operating Expenses 0 0 0 0 0 0 -0.123
Operating Income -181 -158.8 -114.4 -71.66 -43.22 -17.19 -9.92
Net Non-Operating Interest 23.73 25.02 14.19 -1.35 0.402 0.069 0.219
Interest Income 23.73 25.02 14.19 2.66 0.402 0.069 0.219
Interest Expense 0 0 0 4.02 0 0 0
Equity & Other Income/(Expense) 0 0 0 5.37 0 0 0
Income Before Tax -157.2 -133.8 -100.2 -67.64 -42.81 -17.12 -9.71
Income Tax Expense 0 0 0 0 0 0 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 -0.069 -0.219
Net Income -157.2 -133.8 -100.2 -67.64 -42.81 -17.05 -9.49
Depreciation and Amortization 2.27 2.29 1.73 0.538 0.272 0.185 0.123
EBITDA -178.7 -156.5 -112.6 -71.12 -42.94 -17.01 -9.8
Earnings Per Share (EPS) -1.58 -1.45 -1.57 -1.26 -0.86 -0.35 -0.19
Diluted Earnings Per Share -1.58 -1.45 -1.57 -1.26 -0.86 -0.35 -0.19
Weighted Average Shares Outstanding 105.5 92.41 63.72 53.59 49.5 49.22 49.22
Diluted Weighted Average Shares Outstanding 105.5 92.41 63.72 53.59 49.5 49.22 49.22
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program